GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Huahai Pharmaceutical Co Ltd (SHSE:600521) » Definitions » Short-Term Debt

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Short-Term Debt : ¥2,425 Mil (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zhejiang Huahai Pharmaceutical Co Short-Term Debt?

Zhejiang Huahai Pharmaceutical Co's Short-Term Debt for the quarter that ended in Mar. 2024 was ¥2,425 Mil.

Zhejiang Huahai Pharmaceutical Co's quarterly Short-Term Debt increased from Sep. 2023 (¥1,526 Mil) to Dec. 2023 (¥1,583 Mil) and increased from Dec. 2023 (¥1,583 Mil) to Mar. 2024 (¥2,425 Mil).

Zhejiang Huahai Pharmaceutical Co's annual Short-Term Debt increased from Dec. 2021 (¥1,314 Mil) to Dec. 2022 (¥1,397 Mil) and increased from Dec. 2022 (¥1,397 Mil) to Dec. 2023 (¥1,583 Mil).

Zhejiang Huahai Pharmaceutical Co Short-Term Debt Historical Data

The historical data trend for Zhejiang Huahai Pharmaceutical Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Huahai Pharmaceutical Co Short-Term Debt Chart

Zhejiang Huahai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,417.37 1,004.75 1,313.82 1,396.60 1,582.55

Zhejiang Huahai Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,685.99 2,206.33 1,525.86 1,582.55 2,424.67

Zhejiang Huahai Pharmaceutical Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Zhejiang Huahai Pharmaceutical Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Zhejiang Huahai Pharmaceutical Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Huahai Pharmaceutical Co Ltd (SHSE:600521) » Definitions » Short-Term Debt
Comparable Companies
SHSE:600518 SHSE:600329 SHSE:600380 SZSE:002262 SHSE:600062 SHSE:603707 SZSE:300142 SHSE:600535 SHSE:600129 SZSE:002773 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
Economic Development Zone, Xunqiao Town, Linhai, Taizhou, Zhejiang, CHN, 317024
Website
http://www.huahaipharm.com
Zhejiang Huahai Pharmaceutical Co Ltd provides formulations, active pharmaceutical ingredients, and intermediates in China and internationally. The company also offers pril products, including captopril, enalapril, and lisinopril.
Executives
Chen Bao Hua Director
Shang Fei senior management
Du Jun Director
Su Yan Director
Chen Dun Yuan senior management
Li Hong Director
Guo Si Jia senior management
Li Min senior management
Xu Bo senior management
Wang Jie senior management
Chen Qi Mao senior management
Zhang Hong senior management
Zhang Mei senior management
Zhu Yong Hua Directors, senior managers
Wang Yi Hua senior management

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Headlines

No Headlines